Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp232 | Adrenal and Neuroendocrine - Clinical (1) | ECE2019

Can phthalates impair liver function?

Medic-Stojanoska Milica , Milosevic Natasa , Milanovic Maja , Stojanoski Stefan , Vukovic Bojan , Icin Tijana , Bajkin Ivana , Stepanovic Kristina , Sudji Jan , Milic Natasa

Introduction: The impairment of liver function and enhancement for NAFLD development may be attributed to the ubiquitous exposure to endocrine disrupting chemicals such as phthalates. In this study the urinary levels of monoethyl phthalate (MEP) and mono-(2-ethylhexyl) phthalate (MEHP) were compared with the parameters of hepatic function and lipids in overweight, diabetic patients and normal weight population.Methods and patients: In 305 volunteers of b...

ea0070aep158 | Bone and Calcium | ECE2020

Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: European subanalysis of a global patient survey

Siggelkow Heide , Germak John , Marelli Claudio , Chen Kristina , Dahl-Hansen Helen , Glenister Elizabeth , Bent-Ennakhil Nawal , Judge Davneet , Mycock Katie , Clarke Bart L

Although chronic hypoparathyroidism is known to negatively affect health-related quality of life (HRQoL), burden of illness is less well defined in patients whose disease is not adequately controlled on conventional therapy. We report burden of illness for the European subset of a patient survey in 13 countries globally. 398 adults with chronic hypoparathyroidism not adequately controlled on conventional therapy (recruited by treating physician or patient association) complete...

ea0070aep605 | Pituitary and Neuroendocrinology | ECE2020

An education programme for patients with pituitary tumours and their relatives; preliminary results

Tiberg Persson Jenny , Jakobsson Sofie , Cid Käll Kristina , Kullin Lena , Olofsson Ann-Charlotte , Wittboldt Ia , Skoglund Thomas , Trimpou Penelope , Jakobsson Ung Eva , Johannsson Gudmundur

Background: Patients with pituitary tumour live with life-long consequences of their disease. The first year after pituitary surgery represents a time period of symptoms, fear of tumour recurrence, existential concerns as well as extensive medical evaluations and decisions about hormone replacement. To increase wellbeing, a person-centred care practice up to 1 year after pituitary surgery covering self-management support, accessibility and continuity has been implemented and a...

ea0056oc3.4 | New insights in bone disorders | ECE2018

Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy

Chen Kristina , Rubin Mishaela , Mu Fan , Swallow Elyse , Zhao Jing , Wang Jessie , Krasner Alan , Sherry Nicole , Signorovitch James , Ketteler Markus , Bilezikian John

Standard therapy (ST) for chronic hypoparathyroidism (HPT) includes calcium and active vitamin D supplementation, which can be associated with an increased risk of renal complications. This study compared renal function change, assessed by estimated glomerular filtration rate (eGFR) over 5 years between HPT patients receiving rhPTH1-84 as an adjunct to ST and a historical control cohort without rhPTH1-84. rhPTH1-84-treated HPT patients were selected from two single-arm, long-t...

ea0056p228 | Calcium & Vitamin D metabolism | ECE2018

The coexistence of primary hyperparathyroidism with different auto-antibodies and autoimmune diseases

Novakovic-Paro Jovanka , Icin Tijana , Bajkin Ivana , Dejanovic Bozidar , Stepanovic Kristina , Vukovic Bojan , Benc Damir , Tomic-Naglic Dragana , Pejin Radoslav , Milankov Andrijana , Medic-Stojanoska Milica

Introduction: The coexistence of primary hyperparathyroidism with autoimmune diseases is described very rarely in the literature so far. There are only few cases of immune-mediated hyperparathyroidism, associated with anti-calcium- sensing receptor autoantibodies, frequently in context with other immune diseases. Spontaneous remission of primary hyperparathyroidism in anti-TNF therapy of psoriatic arthritis has also been described in one case. Prevalence of positive antithyroi...

ea0056p241 | Calcium & Vitamin D metabolism | ECE2018

Burden of illness among patients with chronic hypoparathyroidism not adequately controlled with standard therapy by self-perception

Siggelkow Heide , Clarke Bart L. , Dahl-Hansen Helen , Glenister Elizabeth , Judge Davneet , Bent-Ennakhil Nawal , Gibson Katie , Germak John , Chen Kristina , Marelli Claudio , Bollerslev Jens

Significant knowledge gaps exist regarding the humanistic effects of chronic hypoparathyroidism (HPT), a rare, debilitating condition. We provide interim results from a global survey conducted to characterise the burden associated with chronic HPT from the patient perspective. An anonymous, self-reported survey (online or paper) was conducted in patients with chronic HPT, not adequately controlled with standard therapy by self-perception, from 12 countries through physicians o...

ea0073aep16 | Adrenal and Cardiovascular Endocrinology | ECE2021

Typical obese patient with an adrenal incidentaloma is a menopausal female with an unilateral nonfunctioning tumor – a single centre experience

Marina Ljiljana , Sojat Antoan Stefan , Vujovic Svetlana , Tancic-Gajic Milina , Arizanovic Zorana , Lazovic Jelena Milin , Kendereski Aleksandra , Dunja-Simona Petkovic , Saravinovska Kristina , Stankovic David , Rosic Natasa , Ivovic Miomira

IntroductionThe connection between obesity and tumorigenesis has been well established.AimThe aim of this study was to elucidate if there are any demographic and functional differences in adrenal incidentalomas (AI) with respect to different body mass index (BMI) categories.Patients and methodsThis was an observational, cross sectional study. The AI cohort consist...

ea0093p22 | Guided Poster Tour 2: Miscellaneous | EYES2023

Post-covid precipitates cardiovascular risk in women – premenstrual syndrome worsening, weight gain, and mental health disturbances

Saravinovska Kristina , Marina Ljiljana , Delic Neda , Sojat Antoan Stefan , Petkovic Dunja Simona , Petkovic Tijana , Antic Natalija , Mihajlovic Sladjana , Lackovic Milan , Radonjic Nevena , Ivovic Miomira , Arizanovic Zorana , Vujovic Svetlana

Background: Premenstrual syndrome (PMS) and mental health disturbances have been identified as cardiovascular risk factors.Objectives: To determine the effects of Sars-CoV-2 infection on PMS and mental health.Methods: An anonymous survey about reproductive and mental health was shared with women of reproductive age between May and December, 2022. All women used their menstrual cycle (MC) diary while filling out the survey. Surveys ...

ea0081ep788 | Pituitary and Neuroendocrinology | ECE2022

Case report in a patient with insulinoma

Cheshlaroska Markushoska Katerina , Todorova Biljana , Cheshlaroska Hristina , Jovanoska Belma Bilaloglu

Introduction: An insulinoma is a neuroendocrine tumor, deriving mainly from pancreatic islet cells, that constantly produces insulin even when blood sugar is very low. Insulinomas are the most common cause of hypoglycemia resulting from endogenous hyperinsulinism. Biochemical diagnosis of insulinoma is established during prolonged fasting test (up to 72 hours) in 95 % of patients, 90-95% of insulinomas can be diagnosed during 48 hours of prolonged fasting. After biochemical co...

ea0037ep799 | Pituitary: clinical | ECE2015

Outstanding growth response to GH replacement therapy in three different cases of GH deficiency

Saranac Ljiljana , Djuric Zlatko , Markovic Ivana , Stamenkovic Hristina , Lazarevic Dragoljub

Introduction: Growth response in GH deficient children during GH replacement therapy rarely fulfil our projections and patient’s expectations. We here report three cases with outstanding growth response.Case reports: First patient was diagnosed as gluten enteropathy in early childhood, but the diet didn’t improve his growth. At age of 7 years the diagnosis of isolated GH deficiency (GHD) was established and GH substitution therapy introduced. N...